James Peyer - 18 Feb 2021 Form 4/A - Amendment Insider Report for Sensei Biotherapeutics, Inc. (SNSE)

Role
Director, 10%+ Owner
Signature
/s/ Sarah Field, Attorney-in-Fact
Issuer symbol
SNSE
Transactions as of
18 Feb 2021
Net transactions value
+$14,852
Form type
4/A - Amendment
Filing time
21 Apr 2022, 16:22:23 UTC
Date Of Original Report
19 Feb 2021
Previous filing
01 Aug 2022
Next filing
21 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SNSE Common Stock Purchase $14,852 +752 +0.02% $19.75* 4,690,905 18 Feb 2021 See footnote F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 4 is being amended to correct the number of shares purchased. The original Form 4 filed on February 19, 2021, overstated the number of shares purchased.
F2 These shares are held by Cambrian Biopharma, Inc., a Delaware corporation ("Cambrian").The Reporting Person is the Chief Executive Officer of Cambrian and in such capacity may direct the voting and disposition of the shares held by Cambrian, subject in certain instances to the approval of Cambrian's Board of Directors. Mr. Peyer disclaims beneficial ownership of such shares.